Clearline Capital LP 13D and 13G filings for TherapeuticsMD, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 4:25 pm Sale | 2024-12-31 | 13G | TherapeuticsMD, Inc. TXMD | Clearline Capital LP | 635,222 5.500% | -1,400 (-0.22%) | Filing |
| 2024-11-12 4:40 pm Purchase | 2024-09-30 | 13G | TherapeuticsMD, Inc. TXMD | Clearline Capital LP | 636,622 5.520% | 636,622 (New Position) | Filing |